Glucocorticoid-Induced Osteoporosis: The Potential Role of Romosozumab
Glucocorticoid (GC)-induced osteoporosis (GIOP) is a major problem in patients with rheumatic diseases. The deleterious effect of GC on bone turnover is rapid and dose-dependent, with a predilection on the trabecular bone, resulting in vertebral fractures. Early recognition and prompt treatment of G...
| 主要な著者: | , |
|---|---|
| フォーマット: | 論文 |
| 言語: | English |
| 出版事項: |
World Scientific Publishing
2020-12-01
|
| シリーズ: | Journal of Clinical Rheumatology and Immunology |
| 主題: | |
| オンライン･アクセス: | http://www.worldscientific.com/doi/epdf/10.1142/S2661341720300074 |